WHO IRISopen access
Accelerating the development of affordable HIV drug resistance testing for use in low-and middle-income settings: report of a virtual meeting, 27 January 2025
hiv infections, acquired immunodeficiency syndrome, hiv-1, hiv seropositivity, hiv integrase inhibitors, drug resistance, viral, antiretroviral therapy, highly active, treatment failure
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 155915
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.